Blunted d-amphetamine response in major depressive disorder (MDD).

被引:0
|
作者
Tremblay, LK
Naranjo, CA
Busto, U
Cardenas, L
机构
[1] Univ Toronto, Dept Pharmacol, CAMH, SHSC, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychol, CAMH, SHSC, Toronto, ON, Canada
[3] Univ Toronto, Dept Med, CAMH, SHSC, Toronto, ON, Canada
关键词
D O I
10.1016/S0009-9236(99)80098-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PI98
引用
收藏
页码:141 / 141
页数:1
相关论文
共 50 条
  • [31] Results of a whole genome association study for Major Depressive Disorder (MDD)
    Sakul, Hakan
    Hinds, David A.
    Frazer, Kelly A.
    Cox, David R.
    Hyde, Craig
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (07) : 693 - 693
  • [32] The neurocognitive profile of post-traumatic stress disorder (PTSD), major depressive disorder (MDD), and PTSD with comorbid MDD
    Koopowitz, Sheri-Michelle
    Mare, Karen Thea
    Zar, Heather J.
    Stein, Dan J.
    Ipser, Jonathan C.
    [J]. BRAIN AND BEHAVIOR, 2021, 11 (04):
  • [33] Superiority of Escitalopram over Paroxetine in the treatment of Major Depressive Disorder (MDD)
    Kasper, S.
    Baldwin, D.
    Boulenger, J. P.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (04) : 337 - 337
  • [34] Amygdala Volume Is Associated with Helplessness in Adults with Major Depressive Disorder (MDD)
    Buchholz, Jennifer L.
    Rosso, Isabelle M.
    Killgore, William D. S.
    Fukunaga, Rena
    Olson, Elizabeth A.
    Demers, Lauren A.
    Rauch, Scott L.
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 65S - 65S
  • [35] Volume of the midbrain dorsal raphe nucleus in major depressive disorder (MDD)
    Stockmeier, CA
    Saenz, MD
    Smith, E
    Miguel-Hidalgo, JJ
    Friedman, L
    Rajkowska, G
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 183S - 183S
  • [36] PLASMA GH RESPONSE TO D-AMPHETAMINE AND L-AMPHETAMINE IN MONKEYS
    SMITH, GP
    RUSS, RD
    STOKES, P
    DUCKETT, GE
    ROOT, AW
    [J]. HORMONE AND METABOLIC RESEARCH, 1977, 9 (04) : 339 - 340
  • [37] Adjunctive aripiprazole in major depressive disorder (MDD): efficacy and predictors of remission
    Nelson, J. C.
    Thase, M. E.
    Baker, R. A.
    Rollin, L. M.
    McQuade, R. D.
    Marcus, R. N.
    Berman, R. M.
    Wisniewski, S. R.
    Gismondi, R.
    Loze, J. Y.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S386 - S386
  • [38] Serotonin Transporter Polymorphism in Major Depressive Disorder (MDD), Psychiatric Disorders, and in MDD in Response to Stressful Life Events: Causes and Treatment with Antidepressant
    Daniele, Antonella
    Divella, Rosa
    Paradiso, Angelo
    Mattioli, Vittorio
    Romito, Francesca
    Giotta, Francesco
    Casamassima, Porzia
    Quaranta, Michele
    [J]. IN VIVO, 2011, 25 (06): : 895 - 901
  • [39] Efficacy and safety of sertraline in the treatment of pediatric major depressive disorder (MDD)
    Wagner, K
    Donnelly, C
    Wohlberg, C
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S231 - S232
  • [40] ECONOMIC ANALYSIS OF ESCITALOPRAM (GENERIC DRUG) IN MAJOR DEPRESSIVE DISORDER (MDD)
    Walczak, J.
    Nogas, G.
    Garbacka, M.
    Obrzut, G.
    Pieniazek, I
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A114 - A114